| Product Code: ETC13143225 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Radiopharmaceutical Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Radiopharmaceutical Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Radiopharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 North America Radiopharmaceutical Market - Industry Life Cycle |
3.4 North America Radiopharmaceutical Market - Porter's Five Forces |
3.5 North America Radiopharmaceutical Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Radiopharmaceutical Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 North America Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 North America Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2021 & 2031F |
3.9 North America Radiopharmaceutical Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.10 North America Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 North America Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Radiopharmaceutical Market Trends |
6 North America Radiopharmaceutical Market, 2021 - 2031 |
6.1 North America Radiopharmaceutical Market, Revenues & Volume, By Types, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Radiopharmaceutical Market, Revenues & Volume, By Diagnostic Nuclear Medicine, 2021 - 2031 |
6.1.3 North America Radiopharmaceutical Market, Revenues & Volume, By Therapeutic Nuclear Medicine, 2021 - 2031 |
6.2 North America Radiopharmaceutical Market, Revenues & Volume, By Applications, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Radiopharmaceutical Market, Revenues & Volume, By Diagnostic Applications, 2021 - 2031 |
6.2.3 North America Radiopharmaceutical Market, Revenues & Volume, By Therapeutic Applications, 2021 - 2031 |
6.3 North America Radiopharmaceutical Market, Revenues & Volume, By Procedural Volume Assessment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Radiopharmaceutical Market, Revenues & Volume, By Diagnostic Procedures, 2021 - 2031 |
6.3.3 North America Radiopharmaceutical Market, Revenues & Volume, By Therapeutic Procedures, 2021 - 2031 |
6.4 North America Radiopharmaceutical Market, Revenues & Volume, By Source, 2021 - 2031 |
6.4.2 North America Radiopharmaceutical Market, Revenues & Volume, By Nuclear Reactors, 2021 - 2031 |
6.4.3 North America Radiopharmaceutical Market, Revenues & Volume, By Cyclotrons, 2021 - 2031 |
6.5 North America Radiopharmaceutical Market, Revenues & Volume, By End-users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Radiopharmaceutical Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 North America Radiopharmaceutical Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.5.4 North America Radiopharmaceutical Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.5.5 North America Radiopharmaceutical Market, Revenues & Volume, By Cancer Research Institutes, 2021 - 2031 |
6.5.6 North America Radiopharmaceutical Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Radiopharmaceutical Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Radiopharmaceutical Market, Revenues & Volume, By Types, 2021 - 2031 |
7.2.1 United States (US) Radiopharmaceutical Market, Revenues & Volume, By Types, 2021 - 2031 |
7.2.2 Canada Radiopharmaceutical Market, Revenues & Volume, By Types, 2021 - 2031 |
7.2.3 Rest of North America Radiopharmaceutical Market, Revenues & Volume, By Types, 2021 - 2031 |
7.3 North America Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
7.3.1 United States (US) Radiopharmaceutical Market, Revenues & Volume, By Applications, 2021 - 2031 |
7.3.2 Canada Radiopharmaceutical Market, Revenues & Volume, By Applications, 2021 - 2031 |
7.3.3 Rest of North America Radiopharmaceutical Market, Revenues & Volume, By Applications, 2021 - 2031 |
7.4 North America Radiopharmaceutical Market, Revenues & Volume, By Procedural Volume Assessment, 2021 - 2031 |
7.4.1 United States (US) Radiopharmaceutical Market, Revenues & Volume, By Procedural Volume Assessment, 2021 - 2031 |
7.4.2 Canada Radiopharmaceutical Market, Revenues & Volume, By Procedural Volume Assessment, 2021 - 2031 |
7.4.3 Rest of North America Radiopharmaceutical Market, Revenues & Volume, By Procedural Volume Assessment, 2021 - 2031 |
7.5 North America Radiopharmaceutical Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5.1 United States (US) Radiopharmaceutical Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5.2 Canada Radiopharmaceutical Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5.3 Rest of North America Radiopharmaceutical Market, Revenues & Volume, By Source, 2021 - 2031 |
7.6 North America Radiopharmaceutical Market, Revenues & Volume, By End-users, 2021 - 2031 |
7.6.1 United States (US) Radiopharmaceutical Market, Revenues & Volume, By End-users, 2021 - 2031 |
7.6.2 Canada Radiopharmaceutical Market, Revenues & Volume, By End-users, 2021 - 2031 |
7.6.3 Rest of North America Radiopharmaceutical Market, Revenues & Volume, By End-users, 2021 - 2031 |
8 North America Radiopharmaceutical Market Key Performance Indicators |
9 North America Radiopharmaceutical Market - Export/Import By Countries Assessment |
10 North America Radiopharmaceutical Market - Opportunity Assessment |
10.1 North America Radiopharmaceutical Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Radiopharmaceutical Market Opportunity Assessment, By Types, 2021 & 2031F |
10.3 North America Radiopharmaceutical Market Opportunity Assessment, By Applications, 2021 & 2031F |
10.4 North America Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2021 & 2031F |
10.5 North America Radiopharmaceutical Market Opportunity Assessment, By Source, 2021 & 2031F |
10.6 North America Radiopharmaceutical Market Opportunity Assessment, By End-users, 2021 & 2031F |
11 North America Radiopharmaceutical Market - Competitive Landscape |
11.1 North America Radiopharmaceutical Market Revenue Share, By Companies, 2022 |
11.2 North America Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here